Catalyst Wire Dossier Catalyst Wire Dossier

Levobetaxolol Hydrochloride Eye Drops

levobetaxolol hydrochloride · Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Levobetaxolol Hydrochloride Eye Drops, covering 2023-05-12 to 2023-05-12. Get the full timeline:

Most recent: Clinical Trial Update: Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension [Phase 3]

See pricing